Google
DGX 株価分析 — QUEST DIAGNOSTICS INCORPORATED (Healthcare >> Diagnostics & Research)
DGX に関するよくある質問
DGXのPER（株価収益率）は？
QUEST DIAGNOSTICS INCORPORATED（DGX）は現在PER 24.35倍で取引されています。
DGXのROE（自己資本利益率）は？
QUEST DIAGNOSTICS INCORPORATEDのROEは14.13%です。
DGXの配当利回りは？
QUEST DIAGNOSTICS INCORPORATEDの配当利回りは1.41%です。
DGXの品質スコア（Quality Score）は？
当社のAIはDGXの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
DGXは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
DGXはどのセクターに属しますか？
QUEST DIAGNOSTICS INCORPORATEDはHealthcare >> Diagnostics & Researchセクターに分類されます（NYSE市場）
DGX AI Analysis Summary
Our AI summary for DGX: QUEST DIAGNOSTICS INCORPORATED (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 24.35, ROE of 14.13%, a dividend yield of 1.41%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 233.01
Price
-1.29
(-0.55%)
Day Change
|
|
|---|
DGX, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
1533
|
| Magic Formula Rank by ROE |
1533
|
| Magic Formula Rank by ROIC |
1781
|
| Price | 233.01 |
| PBV / Sector |
3.31 / -29.69
|
| Earning Per Share | 9.57 |
| PE / Sector |
24.35 / 48.18
|
| PEG or PE/Growth / Sector |
7.20 / 1.64
|
| Average 1M Daily Value |
246.77 M
GREAT
|
| Average 1W Daily Value |
259.50 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
50% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:43 |
| Symbol | DGX |
| Name | QUEST DIAGNOSTICS INCORPORATED |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NYSE |
| Listed Shares | 110.37 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 25,860.48 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 Plaza Drive, Secaucus, NJ, United States, 07094
Phone: 973 520 2700
Website: https://www.questdiagnostics.com
Employees: 46,000
Description: Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
